Help us test a new investigational medication for Coeliac disease!
A gluten-free diet is the only current treatment for Coeliac disease. This study will research whether subcutaneous doses of the trial medication can target the immune response in people with Coeliac disease to protect them from the effects of gluten exposure.
20 x appointments, 1 x phone call & daily diary entries/doses at-home over approximately 7 months.
|Screening Period||Dosing Period||Maintenance Period||Follow-Up|
|Appointments at Linear||1||11||7||1|
|At-home Questionnaire &/or Dosing||3||–||19||–|
|Approximate Appointment Time (At Linear)||9 hrs||1 x 7hrs & 10 x 1hr||4 x 5-6hrs, 2 x 6hrs, 1 x 1-2hrs||1 x 1-2hrs|
Participants will be reimbursed for any reasonable expenses associated with clinic appointments, up to a maximum of $65 per in-house visit.
- Healthy Males and Females between the ages of 18 and 70
- Have a diagnosis of Coeliac Disease confirmed with documentation (intestinal biopsy).
- Have maintained Gluten-free Diet (GFD) for at least 12 consecutive months prior to screening.
- Willing to consume a moderate amount of gluten (approximately 6 g of gluten protein) once at the screening visit and at a maximum of two other time points for the study.
Register your interest below.